Ashwani K. Dhingra et al. 2024. The future of cancer immunotherapy: Advances in checkpoint inhibitors and chimeric antigen receptor-T cells discussing recent progress in immunotherapy for cancer, focusing on checkpoint inhibitors and chimeric antigen receptor-T cell therapies. Innovations in Pharmacy Planet. 12, 4 (Dec. 2024), 69–72.